Mark Baxter

3.4k total citations
86 papers, 1.2k citations indexed

About

Mark Baxter is a scholar working on Surgery, Oncology and Geriatrics and Gerontology. According to data from OpenAlex, Mark Baxter has authored 86 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 23 papers in Oncology and 21 papers in Geriatrics and Gerontology. Recurrent topics in Mark Baxter's work include Frailty in Older Adults (21 papers), Hip and Femur Fractures (16 papers) and Trauma and Emergency Care Studies (13 papers). Mark Baxter is often cited by papers focused on Frailty in Older Adults (21 papers), Hip and Femur Fractures (16 papers) and Trauma and Emergency Care Studies (13 papers). Mark Baxter collaborates with scholars based in United Kingdom, United States and Ireland. Mark Baxter's co-authors include Vikas Khanduja, Thomas Jones, Harnish P. Patel, Kinda Ibrahim, Helen C. Roberts, Avan Aihie Sayer, Carl May, Russell Petty, Naoki Nakano and Hemant Pandit and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Mark Baxter

70 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Baxter United Kingdom 17 332 241 176 150 149 86 1.2k
Marja Blom Finland 27 562 1.7× 311 1.3× 56 0.3× 57 0.4× 113 0.8× 55 2.2k
Richard Hellman United States 17 665 2.0× 230 1.0× 108 0.6× 56 0.4× 126 0.8× 40 3.8k
Estíbaliz Loza Spain 29 453 1.4× 141 0.6× 105 0.6× 24 0.2× 130 0.9× 154 2.4k
Ulf Persson Sweden 34 496 1.5× 204 0.8× 243 1.4× 59 0.4× 285 1.9× 163 3.3k
Leila J. Mady United States 22 361 1.1× 167 0.7× 229 1.3× 22 0.1× 203 1.4× 98 1.9k
Zulma Ortiz Argentina 15 167 0.5× 212 0.9× 125 0.7× 31 0.2× 85 0.6× 35 1.6k
María José Martínez‐Zapata Spain 29 842 2.5× 96 0.4× 157 0.9× 26 0.2× 106 0.7× 87 2.4k
Noritoshi Fukushima Japan 23 224 0.7× 520 2.2× 69 0.4× 61 0.4× 74 0.5× 76 1.9k
Lars‐Erik Strender Sweden 24 301 0.9× 96 0.4× 134 0.8× 25 0.2× 169 1.1× 76 1.6k
Zoé Paskins United Kingdom 17 360 1.1× 170 0.7× 139 0.8× 32 0.2× 46 0.3× 110 1.6k

Countries citing papers authored by Mark Baxter

Since Specialization
Citations

This map shows the geographic impact of Mark Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Baxter more than expected).

Fields of papers citing papers by Mark Baxter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Baxter. The network helps show where Mark Baxter may publish in the future.

Co-authorship network of co-authors of Mark Baxter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Baxter. A scholar is included among the top collaborators of Mark Baxter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Baxter. Mark Baxter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Spender, Lindsay C., Mark Baxter, K. E. Walker, et al.. (2025). AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma. British Journal of Cancer. 133(5). 709–722.
3.
O’Hanlon, Shane, Mark Baxter, & Gábor Liposits. (2025). Practical aspects of managing multimorbidity in older adults with cancer. Current Opinion in Supportive and Palliative Care. 20(1). 5–10.
4.
King, Katherine Callen, et al.. (2025). Treatment Considerations for Severe Osteoporosis in Older Adults. Drugs & Aging. 42(5). 395–412. 2 indexed citations
5.
Baxter, Mark, Michael Rowe, Deborah J. Scott, et al.. (2024). UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study. SHILAP Revista de lepidopterología. 3(1). e000459–e000459. 2 indexed citations
6.
Evans, Jonathan, Malcolm Reed, Cliff Shelton, et al.. (2024). Post-operative periprosthetic femoral fractures in England: Patient profiles and short-term outcomes. Injury. 56(2). 112026–112026.
7.
Dearden, Helen Clare, Michael Rowe, Deborah J. Scott, et al.. (2024). A United Kingdom prospective, multicentre, observational cohort study investigating tolerance of anti-cancer systemic therapy in the elderly: The TOASTIE study.. Journal of Clinical Oncology. 42(16_suppl). 1521–1521.
8.
9.
Baxter, Mark, Lindsay C. Spender, Shaun Walsh, et al.. (2023). Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial. Cancers. 15(9). 2591–2591. 2 indexed citations
10.
Baxter, Mark, et al.. (2023). Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study. British journal of surgery. 110(4). 456–461. 4 indexed citations
11.
Halter, Mary, Heather Jarman, Phil Moss, et al.. (2023). Configurations and outcomes of acute hospital care for frail and older patients with moderate to major trauma: a systematic review. BMJ Open. 13(2). e066329–e066329. 6 indexed citations
12.
13.
Baxter, Mark, et al.. (2023). Sacral ependymoma presents 20 years after initial posterior fossa lesion. BMJ Case Reports. 16(10). e256611–e256611. 2 indexed citations
14.
Kristeleit, Hartmut, Vivek Misra, Mark Baxter, et al.. (2022). Eribulin Treatment for Patients with Metastatic Breast Cancer: The UK Experience – A Multicenter Retrospective Study. Oncology. 100(12). 666–673. 2 indexed citations
15.
Petty, Russell, et al.. (2021). Cancer Treatment Helpline: a retrospective study of the NHS Tayside experience. BMJ Open Quality. 10(2). e001488–e001488. 2 indexed citations
16.
Bretherton, Chris, H A Claireaux, Jonathan Gower, et al.. (2021). Research priorities for the management of complex fractures: a UK priority setting partnership with the James Lind Alliance. BMJ Open. 11(11). e057198–e057198. 7 indexed citations
17.
Swinson, Daniel, David A. Cairns, Mark Baxter, et al.. (2021). Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial. Journal of Geriatric Oncology. 13(3). 287–293. 12 indexed citations
18.
19.
Fernandez, Miguel A., Richard Grant, Philip Bell, et al.. (2018). Research priorities in fragility fractures of the lower limb and pelvis: a UK priority setting partnership with the James Lind Alliance. BMJ Open. 8(10). e023301–e023301. 28 indexed citations
20.
Baxter, Mark, Catherine Gooday, & Ketan Dhatariya. (2015). The effect of radiological contrast media on renal function and inflammatory markers in people with diabetes – a clinical study and review. The British Journal of Diabetes. 15(4). 187–187.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marja Blom Breakdown of academic impact, for papers by Richard Hellman Breakdown of academic impact, for papers by Estíbaliz Loza Breakdown of academic impact, for papers by Ulf Persson Breakdown of academic impact, for papers by Leila J. Mady Breakdown of academic impact, for papers by Zulma Ortiz Breakdown of academic impact, for papers by María José Martínez‐Zapata Breakdown of academic impact, for papers by Noritoshi Fukushima Breakdown of academic impact, for papers by Lars‐Erik Strender Breakdown of academic impact, for papers by Zoé Paskins
Rankless by CCL
2026